Biolife Solutions Inc (BLFS) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Biolife Solutions Inc   (NASDAQ: BLFS)

Select the Financial Report: Select the Period:


Description of Biolife Solutions Inc's Business Segments


Biolife Solutions Inc is a prominent developer, manufacturer, and supplier of proprietary biopreservation media products and services specifically designed for the preservation of cells, tissues, and organs. The company operates across several segments that cater to the biotechnology, pharmaceutical, and medical research markets, offering an extensive array of products and services. Below is a detailed overview of the key segments, products, and services provided by Biolife Solutions Inc:

1. Biopreservation Media

Biolife Solutions Inc leads the market in biopreservation media products that improve the viability, safety, and effectiveness of biologic therapies and clinical products. These media are essential in various applications including cell therapy, regenerative medicine, tissue engineering, and gene therapy. The primary biopreservation media offerings include:

- HypoThermosole FRS: This advanced biopreservation medium is formulated to be serum-free and protein-free. It has been extensively validated to enhance cell viability and functionality during the storage and transportation phases. HypoThermosole FRS creates optimal conditions for preserving cells, organs, and tissues, thereby minimizing cellular stress and damage.

- CryoStore CS10: A high-performance cryopreservation medium designed for the safe freezing of cells such as stem cells, T cells, and natural killer cells. CryoStore CS10 is known for its ability to enhance the viability and functional recovery of cells post-thawing, making it ideal for applications requiring high cell performance after preservation.

- CryoStore CS5: Tailored specifically for long-term storage, CryoStore CS5 is a clinical-grade biopreservation medium that effectively preserves cells, tissues, and organs at ultra-low temperatures. This product ensures high viability and function over extended periods, thus safeguarding the integrity of biologic samples during storage.

Contract Development and Manufacturing Services

In addition to its biopreservation media, Biolife Solutions Inc offers comprehensive contract development and manufacturing services tailored for companies in the biotechnology, pharmaceutical, and diagnostic industries. These services include:

- Biopreservation Media Development: Custom formulation and optimization services are provided to meet the specific preservation needs of client samples, allowing for tailored solutions that enhance product outcomes.

- Custom Filling and Vialing: Biolife Solutions Inc offers custom filling and vialing services, ensuring that products are packaged in a manner that maintains their integrity and accessibility throughout the supply chain.

- Labeling and Packaging: The company provides custom labeling and packaging services to ensure products meet regulatory requirements and client branding needs, enabling a seamless integration into client workflows.

Biobanking Services

Biolife Solutions Inc offers state-of-the-art biobanking services for clients requiring secure storage of biological specimens for research or clinical usage. The biobanking services encompass:

- Secure Storage: The firm provides reliable and secure storage solutions for cells, tissues, and biological samples, guaranteeing that clients specimens are stored under optimal conditions.

- Tracking and Traceability: An advanced tracking system is implemented to maintain full traceability of all biological samples stored, allowing clients to monitor their specimens with ease and confidence.

Conclusion

Biolife Solutions Inc stands out as a comprehensive provider of biopreservation media products, contract development and manufacturing services, and biobanking solutions. The company is committed to delivering high-quality products and services that ensure the viability and effectiveness of biologic therapies and clinical products. By leveraging its deep expertise in biopreservation, Biolife Solutions Inc ensures that its clients receive reliable, safe, and effective solutions tailored to their unique requirements in the biotechnology and pharmaceutical sectors.


Composition of Biolife Solutions Inc Revenues by Segments

 

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Total 27.50 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Total 14.85 % -71.39 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 1.19 4.31 %




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Biolife Solutions Inc Divisions, Sales by Country

 


Twelve months ended 2025
BLFS s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 96.12 100 %


Twelve months ended 2025
BLFS s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -4.60 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total 16.86 % -
Product Cell Processing - -
Product Evo and thaw - -
Service Evo and thaw - -
Rental Evo and thaw - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.